| 1 |
/m/0hqz4_g
|
/base/medicaldrugs/fda_load/form_G2M7P15E5P_60_0g_L_660YQ98I10_0_745g_L_8MDF5V39QO_1_68g_L_451W47IQ8X_1_46g_L_36KCS0R750_5_86g_L_powder_oral
|
2012-06-04T14:41:17.0001Z
|
| 2 |
/base/medicaldrugs/fda_load/cvt_35ae2c40f4ce857d2c347c9e0428797d4
cvt
|
/m/0hqz4_g
|
2012-06-04T14:40:02.0001Z
|
| 3 |
/base/medicaldrugs/fda_load/cvt_704e1ace7032913d96ff54fb3706b55b4
cvt
|
/m/0hqz4_g
|
2012-06-04T11:37:45.0001Z
|
| 4 |
/m/0hqz4_g
|
/base/medicaldrugs/fda_load/form_G2M7P15E5P_59_0mg_mL_660YQ98I10_0_743mg_mL_8MDF5V39QO_1_685mg_mL_451W47IQ8X_1_465mg_mL_36KCS0R750_5_685mg_mL_powder_oral
|
2012-06-04T11:36:21.0000Z
|
| 5 |
/m/0hqz4_g
|
/m/0lk81
Sulfate
|
2012-03-15T17:04:46.0001Z
|
| 6 |
/m/0hqz4_g
|
/m/025sf0_
Sodium
|
2012-03-15T17:04:43.0004Z
|
| 7 |
/m/0hyldl8
cvt
|
/m/0hqz4_g
|
2012-01-10T03:28:48.0033Z
|
| 8 |
/m/0hyl2yg
cvt
|
/m/0hqz4_g
|
2012-01-10T03:26:44.0088Z
|
| 9 |
/m/0hyk4hw
cvt
|
/m/0hqz4_g
|
2012-01-10T03:19:58.0044Z
|
| 10 |
/m/0hyjmdg
cvt
|
/m/0hqz4_g
|
2012-01-10T03:16:28.0009Z
|
| 11 |
/m/0hyhnff
cvt
|
/m/0hqz4_g
|
2012-01-10T03:09:43.0045Z
|
| 12 |
/m/0hyh60q
cvt
|
/m/0hqz4_g
|
2012-01-10T03:06:39.0052Z
|
| 13 |
/m/0hygcs5
cvt
|
/m/0hqz4_g
|
2012-01-10T03:00:53.0051Z
|
| 14 |
/m/0hqz4_g
|
/m/0hqtr3z
Peg-3350 and electrolytes 118/1.485/3.37/2.93/11.37 powder for solution
|
2012-01-09T18:09:54.0013Z
|
| 15 |
/m/0hqz4_g
|
/m/0hqtmdp
Polyethylene glycol-3350 and electrolytes with flavor pack 0.863/0.0107/0.0242/0.021/0.0817 powder for solution
|
2012-01-09T17:50:47.0009Z
|
| 16 |
/m/0hqz4_g
|
/m/0hqt7k5
Polyethylene glycol 3350 59 powder for solution
|
2012-01-09T16:48:59.0006Z
|
| 17 |
/m/0hqz4_g
|
/m/0hqt1ws
Peg-3350 and electrolytes 118/1.485/3.37/2.93/11.37 powder for solution
|
2012-01-09T16:18:34.0009Z
|
| 18 |
/m/0hqz4_g
|
/m/0hqsqs8
Polyethylene glycol 3350 and electrolytes for oral solution 59/0.743/1.685/1.465/5.685 powder for solution
|
2012-01-09T15:20:12.0003Z
|
| 19 |
/m/0hqz4_g
|
/m/0hqskkh
Polyethylene glycol 3350, sodium chloride, potassium chloride, sodium bicarbonate, and sodium sulfate anhydrous 60/1.461/0.745/1.68/5.68 powder for solution
|
2012-01-09T14:53:12.0004Z
|
| 20 |
/m/0hqz4_g
|
/m/0hqs83j
Polyethylene glycol-3350 and electrolytes 0.86/0.0108/0.0246/0.0214/0.0829 powder for solution
|
2012-01-09T14:04:03.0006Z
|
| 21 |
/m/0hqz4_g
|
drug_formulation_ingredient_36KCS0R750
/base/medicaldrugs/fda_load
|
2012-01-07T10:33:34.0001Z
|
| 22 |
/m/0hqz4_g
|
/common/topic
|
2012-01-07T10:33:33.0018Z
|
| 23 |
/m/0hqz4_g
|
/medicine/drug_ingredient
|
2012-01-07T10:33:33.0015Z
|
| 24 |
/m/0hqz4_g
|
Sodium sulfate anhydrous
/lang/en
|
2012-01-07T10:33:33.0013Z
|
| 25 |
/m/0hqz4_g
|
36KCS0R750
/authority/us/gov/hhs/fda/srs-unii
|
2012-01-07T10:33:33.0012Z
|
| 26 |
/m/0hqz4_g
|
/boot/all_permission
|
2012-01-07T10:33:33.0011Z
|